New pill aims to stop chemo sickness in breast cancer patients
NCT ID NCT03386617
First seen Mar 07, 2026 · Last updated May 23, 2026 · Updated 12 times
Summary
This study tests a fixed-dose combination of two drugs, netupitant and palonosetron (NEPA), to prevent nausea and vomiting caused by chemotherapy in breast cancer patients. About 55 women in Hong Kong receiving a specific chemo regimen (adriamycin and cyclophosphamide) will take NEPA and track their symptoms. The goal is to see how well it controls nausea and vomiting in the days after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Clinical Oncology, Prince of Wales Hospital
Hong Kong, Hong Kong
Conditions
Explore the condition pages connected to this study.